Literature DB >> 2085096

Demyelination and remyelination in spinal cord lesions of human lymphotropic virus type I-associated myelopathy.

E Ohama1, Y Horikawa, T Shimizu, T Morita, K Nemoto, H Tanaka, F Ikuta.   

Abstract

We describe postmortem findings in a patient with human T lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM). The patient developed the disease 8 years after blood transfusion and showed good response to corticosteroid treatment but died of cardiac failure. Histologically, chronic, mild meningoencephalomyelitis was noted predominantly involving the bilateral lateral and anterior columns of the middle to lower thoracic segments. The spinal cord lesions showed obvious loss of myelinated nerve fibers and fibrillary gliosis with minimal inflammatory cell infiltration. Electron microscopy of the lesion revealed disintegration of the myelin sheaths, regular separation of the minor dense line of the myelin sheaths, and completely demyelinated axons. In addition, remyelinated fibers with thin central myelin sheaths and disproportionately large axons were seen frequently. These findings indicate that primary demyelination and remyelination by oligodendrocytes occur in the spinal cord lesions of HAM.

Entities:  

Mesh:

Year:  1990        PMID: 2085096     DOI: 10.1007/BF00662641

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  22 in total

1.  PERMANENT PARAPLEGIA WITH CIRRHOSIS.

Authors:  B A SCOBIE; W H SUMMERSKILL
Journal:  Arch Intern Med       Date:  1964-06

2.  Demyelination in allergic and Marek's disease virus induced neuritis. Comparative electron microscopic studies.

Authors:  P Lampert; R Garrett; H Powell
Journal:  Acta Neuropathol       Date:  1977-10-10       Impact factor: 17.088

3.  The initial structural lesion in serum-induced demyelination in vitro.

Authors:  M B Bornstein; C S Raines
Journal:  Lab Invest       Date:  1976-10       Impact factor: 5.662

4.  Fine structural aspects of demyelination in vitro. The effects of Guillain-Barré serum.

Authors:  A Hirano; S D Cook; J N Whitaker; P C Dowling; M R Murray
Journal:  J Neuropathol Exp Neurol       Date:  1971-04       Impact factor: 3.685

5.  Spastic paraparesis following portacaval shunts.

Authors:  S S Pant; J J Rebeiz; E P Richardson
Journal:  Neurology       Date:  1968-02       Impact factor: 9.910

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination?

Authors:  G R Moore; U Traugott; L C Scheinberg; C S Raine
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

8.  Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study.

Authors:  K Okuda; T Nakashima; M Okudaira; M Kage; Y Aida; M Omata; M Sugiura; H Kameda; K Inokuchi; S R Bhusnurmath; B A Aikat
Journal:  Liver       Date:  1982-09

9.  [An autopsy case of HTLV-I associated myelopathy (HAM)].

Authors:  H Furuzono; O Nakazato; K Goto; S Akizuki; T Okajima
Journal:  Rinsho Shinkeigaku       Date:  1989-03

10.  Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures.

Authors:  C S Raine; M B Bornstein
Journal:  Lab Invest       Date:  1979-04       Impact factor: 5.662

View more
  3 in total

1.  Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM).

Authors:  A Yoshioka; G Hirose; Y Ueda; Y Nishimura; K Sakai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

2.  Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy.

Authors:  Chihiro Iwao; Kunihiko Umekita; Shunichi Miyauchi; Masatoshi Kimura; Yuki Rikitake; Koushou Iwao; Mao Rikitake; Ayako Aizawa; Takeshi Kawaguchi; Yumi Kariya; Motohiro Matsuda; Ichiro Takajo; Kazutaka Shiomi; Akihiko Okayama
Journal:  Intern Med       Date:  2020-04-23       Impact factor: 1.271

3.  AIDS-myelopathy. A neuropathological study.

Authors:  M Bergmann; F Gullotta; K Kuchelmeister; T Masini; G Angeli
Journal:  Pathol Res Pract       Date:  1993-02       Impact factor: 3.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.